- About the PharmD
- Admissions
- Admissions Overview
- Policies and Disclosures
- Financial Aid and Cost
- Application Process
- Application Process Overview
- Step 1: Minimum Eligibility Requirements
- Step 2: The Application
- Step 3: Interview Process
- Step 4: After Applying
- Frequently Asked Questions and Tips
- Applying Without U.S. Citizenship or Permanent Resident Status
- PharmD-PhD Dual Degree
- Post-Baccalaureate Program
- Student Life
- Curriculum
- Connect
- Info For...
News
Warif Kastoun, PharmD
Mon Jun 10, 2024
Nearly a third of the University of California’s Class of 2024 started their higher education journey at California community colleges, including Warif Kastoun, PharmD, whose plans to run her own local pharmacy in Damascus, Syria, were interrupted by civil war.
Wed Sep 13, 2023
Dean Kathy Giacomini shares how the School’s recent breakthroughs and accomplishments are bringing our new strategic plan to life.
Fri Sep 1, 2023
A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.
Fri Aug 4, 2023
PharmD class welcomed to opportunities and responsibilities of the profession with 22nd annual White Coat Ceremony.
Tue Aug 1, 2023
A team of UCSF PharmD students has been named champions of the 2023 American College of Clinical Pharmacy (ACCP) Clinical Research Challenge (CRC).
Fri Jul 14, 2023
Award from her alma mater recognizes Giacomini as a leading scientist and pharmacogenomics expert.
Tue Jul 11, 2023
School faculty members honored for outstanding contributions.
Mon Jun 26, 2023
Honoring the School’s newest PharmD graduates.
Wed Jun 21, 2023
A team of UCSF PharmD students has taken the top spot in the 2022-2023 Value of Industry Pharmacists (VIP) Case Competition.
Mon Jun 12, 2023
On June 12, The Kidney Project was awarded a $1 million Artificial Kidney Prize from KidneyX for advancing its prototype bioartificial kidney toward a full-sized, human scale, with manufacturing and ultimately clinical trials on the horizon.